Spirulina and Its Bioactive Compounds as Multi-Target Anticancer Agents: Mechanisms, Immune Modulation, and Translational Potential
Medical Sciences · 10.04.2026 · 14 (2) · 189
DOI: 10.3390/medsci14020189 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 10.04.2026. Verfasst von Rym Akrout und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genetics Immunology and Human Pathology, Biology Department, Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis 2092, Tu…. Hauptthemen laut MEDLINE: Spirulina, Antineoplastic Agents, Neoplasms, Biological Products. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Marine-derived natural products are increasingly recognized for their therapeutic potential in cancer and other chronic diseases. Despite significant advances, current cancer treatments remain challenged by toxicity, drug resistance, and limited survival benefits. Natural compounds offer promising alternatives due to their multi-target mechanisms and favorable safety profiles. Among them, Spirulina, a filamentous cyanobacterium, stands out for its rich composition and diverse biological activities. Its anticancer effects involve apoptosis induction via intrinsic and extrinsic pathways, cell cycle arrest at G1/S or G2/M phases, inhibition of angiogenesis through the VEGF/VEGFR2 axis, and suppression of epithelial–mesenchymal transition. These activities are mainly attributed to C-phycocyanin, allophycocyanin, phenolic compounds, and immunomodulatory polysaccharides. Spirulina also exhibits potent immunomodulatory effects by enhancing natural killer cell activity, promoting M1 macrophage polarization, and regulating Th1 and Th17 cytokine responses, highlighting its potential as both an immunotherapeutic and chemoprotective agent. Moreover, preclinical findings suggest it may reduce chemotherapy-associated side effects. However, translation into clinical therapy remains limited by low bioavailability, lack of standardized extracts, and scarce clinical evidence. This review summarizes current mechanistic and immunological insights and highlights the need for optimized formulations, defined dosing strategies, and well-designed clinical trials to validate Spirulina’s potential in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Genetics Immunology and Human Pathology, Biology Department, Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis 2092, Tunisia.
- Pharmacology Unit, School of Pharmacy, Center for Neuroscience, University of Camerino, 62032 Camerino, Italy.
- Faculté des Sciences Médicales et Paramédicales, Institut de NeuroPhysiopathologie (INP), UMR 7051, CNRS, Aix Marseille Université, 13005 Marseille, France.
- Laboratoire de Biologie Intégrative pour l'Innovation Thérapeutique (BioInov), Faculté des Sciences et Techniques (FAST), Université d'Abomey-Calavi, Abomey-Calavi BP 526, Benin.
- Faculty of Sciences, University Campus at El-Manar, Tunis 2092, Tunisia.
ORCID-Profile: Rym Akrout, Khouloud Ayed, Ludovic Leloup, Hanen Attia, Hervé Kovacic, Wassim Y Almawi, Asma Gati
Zitieren
APA
Akrout, R., Ayed, K., Mrizak, H., Leloup, L., Kenou, O. M., Fassinou, F., Bacha, D., Boughriba, R., Attia, H., Kovacic, H., Almawi, W. Y., & Gati, A. (2026). Spirulina and Its Bioactive Compounds as Multi-Target Anticancer Agents: Mechanisms, Immune Modulation, and Translational Potential. Medical Sciences, 14(2), 189. https://doi.org/10.3390/medsci14020189
Vancouver
Akrout R, Ayed K, Mrizak H, Leloup L, Kenou OM, Fassinou F, et al. Spirulina and Its Bioactive Compounds as Multi-Target Anticancer Agents: Mechanisms, Immune Modulation, and Translational Potential. Medical Sciences. 2026;14(2):189. doi:10.3390/medsci14020189
BibTeX
@article{Akrout2026,
author = {Akrout, Rym and Ayed, Khouloud and Mrizak, Hela and Leloup, Ludovic and Kenou, Orace Mathieu and Fassinou, Fidèle and Bacha, Dhouha and Boughriba, Rahma and Attia, Hanen and Kovacic, Hervé and Almawi, Wassim Y and Gati, Asma},
title = {Spirulina and Its Bioactive Compounds as Multi-Target Anticancer Agents: Mechanisms, Immune Modulation, and Translational Potential},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {2},
pages = {189},
doi = {10.3390/medsci14020189}
}
EUVIMED